Issue Date | Title | Involved Person(s) |
2022 | Health technology assessment (HTA) : medicines for dementia due to Alzheimer's and Parkinson's disease | Mattli, R.; Tomonaga, Y.; Tzogiou, C.; Vinci, L.; Sharakin, M., et al |
2022 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis | Mattli, Renato; Grobet, Cécile; Sharakin, Maxim; Pöhlmann, Johannes; Vinci, Linda, et al |